Evidence map›Paper›PMID 25793751›Full record

ArticlePloS one2015

Sequencing and analysis of globally obtained human respiratory syncytial virus A and B genomes.

Michael E Bose, Jie He, Susmita Shrivastava, Martha I Nelson, Jayati Bera, Rebecca A Halpin, Christopher D Town, Hernan A Lorenzi, Daniel E Noyola, Valeria Falcone and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 8 countries.

Michael E BoseMidwest Respiratory Virus Program, Medical College of Wisconsin, Milwaukee, WI, USA.
Jie HeMidwest Respiratory Virus Program, Medical College of Wisconsin, Milwaukee, WI, USA.
Susmita ShrivastavaJ. Craig Venter Institute, Rockville, MD, United States of America.
Martha I NelsonFogarty International Center, National Institutes of Health, Bethesda, MD, United States of America.
Jayati BeraJ. Craig Venter Institute, Rockville, MD, United States of America.
Rebecca A HalpinJ. Craig Venter Institute, Rockville, MD, United States of America.
Christopher D TownJ. Craig Venter Institute, Rockville, MD, United States of America.
Hernan A LorenziJ. Craig Venter Institute, Rockville, MD, United States of America.
Daniel E NoyolaDepartamento de Microbiología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Valeria FalconeDepartment of Virology, Institute for Medical Microbiology and Hygiene, University Medical Center Freiburg, Freiburg, Germany.
Giuseppe GernaLaboratori Sperimentali di Ricerca, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Hans De BeenhouwerDepartment of Microbiology, OLV Hospital Aalst, Aalst, Belgium.
Cristina VidelaClinical Virology Laboratory, Centro de Educación Médica e Investigaciones Clínicas University Hospital, Buenos Aires, Argentina.
Tuckweng KokSchool of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.
Marietjie VenterZoonoses Research Unit, Department Medical Virology, University of Pretoria, Pretoria, South Africa.
John V WilliamsDepartments of Pediatrics and Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Kelly J HenricksonMidwest Respiratory Virus Program, Medical College of Wisconsin, Milwaukee, WI, USA.
J. Craig Venter Institute · USMedical College of Wisconsin · USAutonomous University of San Luis Potosí · MXCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARFogarty International Center · USIstituti di Ricovero e Cura a Carattere Scientifico · ITOnze Lieve Vrouwziekenhuis Hospital · BEUniversity Medical Center Freiburg · DEUniversity of Adelaide · AUUniversity of Pretoria · ZAVanderbilt University · US

Funding

Rapid point-of-care diagnostic for bioterrorism "A" agents and Pandemic influenzaU01AI070428 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2006 to 2010
$8.5M
Multipled POC device for antigen/molecular detection of influenza & other virusesU01AI077988 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI HENRICKSON, KELLY J. · 2008 to 2011
$1.9M
NIAID NIH HHS 5U01AI070428NIAID NIH HHS 5U01AI077988NIAID NIH HHS HHSN272200900007CNIAID NIH HHS U01 AI070428NIAID NIH HHS U01 AI077988
6 · The paper itself

Abstract

backgroundHuman respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in children globally, with nearly all children experiencing at least one infection by the age of two. Partial sequencing of the attachment glycoprotein gene is conducted routinely for genotyping, but relatively few whole genome sequences are available for RSV. The goal of our study was to sequence the genomes of RSV strains collected from multiple countries to further understand the global diversity of RSV at a whole-genome level.

methodsWe collected RSV samples and isolates from Mexico, Argentina, Belgium, Italy, Germany, Australia, South Africa, and the USA from the years 1998-2010. Both Sanger and next-generation sequencing with the Illumina and 454 platforms were used to sequence the whole genomes of RSV A and B. Phylogenetic analyses were performed using the Bayesian and maximum likelihood methods of phylogenetic inference.

resultsWe sequenced the genomes of 34 RSVA and 23 RSVB viruses. Phylogenetic analysis showed that the RSVA genome evolves at an estimated rate of 6.72 × 10(-4) substitutions/site/year (95% HPD 5.61 × 10(-4) to 7.6 × 10(-4)) and for RSVB the evolutionary rate was 7.69 × 10(-4) substitutions/site/year (95% HPD 6.81 × 10(-4) to 8.62 × 10(-4)). We found multiple clades co-circulating globally for both RSV A and B. The predominant clades were GA2 and GA5 for RSVA and BA for RSVB.

conclusionsOur analyses showed that RSV circulates on a global scale with the same predominant clades of viruses being found in countries around the world. However, the distribution of clades can change rapidly as new strains emerge. We did not observe a strong spatial structure in our trees, with the same three main clades of RSV co-circulating globally, suggesting that the evolution of RSV is not strongly regionalized.

Indexed as

Genome, ViralPolymorphism, GeneticBase SequenceEvolution, MolecularHumansMolecular Sequence DataPhylogenyRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus Infections

Identifiers

PMID25793751
PMCPMC4368745
OpenAlexW2106729524

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.